This page contains a Flash digital edition of a book.
Legislation


improvement notices associated with breaches against the Health and Safety (Sharp Instruments in Healthcare) Regulations 2013 on three hospitals in 2013, where there has been a failure to ensure safer sharps are used, investigate the circumstances and causes of incidents and to provide training in the correct use of safer sharps.23


Conclusions


Nurses and pharmacists remain at risk from avoidable sharps/NSI if appropriate precautions and practices are not complied with. It is therefore essential that healthcare providers across Europe give consideration to developing robust, appropriate and effective strategies to reduce the risk associated with sharps/ NSI. Continuing implementation of safe working practices is paramount as is risk assessment, risk elimination, evaluation and introduction of SED following clinical evaluation and training, and awareness of consequences of sharps/NSI. ●


References 1. National Audit Office (NAO). A Safer Place to Work: Improving the Management of Health and Safety Risks to staff in NHS Trusts, 2003. http://tinyurl. com/bnd4zc9 (accessed 14 March 2014).


2. Costigliola V, Letondeur C, Strauss K. Needlestick injuries in European nurses in diabetes. Diabetes Metab 2012;38:S10–S14.


3. Haiduven DJ et al. A survey of percutaneous/ mucocutaneous injury reporting in a public teaching Hospital. J Hosp Infec 1999;41(2):151–4.


4. Health Protection Agency (HPA). Health Protection Services; Public Health Wales; Public Health Agency Northern Ireland; Health Protection Scotland. Eye of the Needle. United Kingdom Surveillance of Significant Occupational Exposure to Bloodborne Viruses in Healthcare Workers. London: Health Protection Agency. December 2012.


5. Hung JC, Krause SJ, Schmit CL. Sensible Approaches to Avoid Needle Stick Accidents in Nuclear Medicine. J Nucl Med Technol 1999;27:290–3.


6. May D, Churchill P. Sharps injury surveillance: a pilot study. AIDS and Hepatitis Digest. 2001;83:4–8.


7. Cardo DM et al. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group. N Engl J Med 1997;337(21):1485–90.


14


8. Centers for Disease Control and Prevention, Hepatitis B FAQs for the Public, 2009a. www.cdc.gov/hepatitis/b/bFAQ.htm


www.hospitalpharmacyeurope.com


(accessed 14 March 2014).


9. Centers for Disease Control and Prevention, Hepatitis C FAQs for the Public, 2009b. www.cdc.gov/hepatitis/C/cFAQ.htm (accessed 14 March 2014).


10. Centers for Disease Control and Prevention, HIV Transmission, 2010. www.cdc.gov/hiv/ resources/qa/transmission.htm (accessed 14 March 2014).


11. World Health Organization. WHO best practices for injections and related procedures toolkit. 2010. whqlibdoc.who.int/publications/2010/ 9789241599252_eng.pdf (accessed 14 March 2014).


12. Adams D, Elliott TS. A comparative user evaluation of three needle-protective devices. Br J Nurs 2003;12(8):470–74.


13. Roff M, Basu S, Adisesh A. Do active safety-needle devices cause spatter contamination? J Hosp Infec 2014;86:221–3.


14. Health and Safety Executive (HSE). An Evaluation of the Efficacy of Safer Sharps Devices: Systematic Review. 2012. www.hse.gov.uk/research/rrpdf/ rr914.pdf (accessed 14 March 2014).


15. Training for Development of Innovative Control Technologies (TDICT). Safety Feature Evaluation Forms. 1998. www.tdict.org/evaluation2.html (accessed 14 March 2014).


16. European Biosafety Network. Prevention of Sharps Injuries in the Hospital and Healthcare Sector Implementation Guidance for the EU Framework Agreement, Council Directive and Associated National Legislation. 2010. www.europeanbiosafetynetwork.eu/EU%20 Sharps%20Injuries%20Implementation%20Guidance. pdf (accessed 14 March 2014).


17. Strauss K, WISE Consensus Group. WISE recommendations to ensure the safety of injections in diabetes. Diabetes Metab 2012;38:S2–S8.


18. Wittmann A. In European Biosafety Network: Toolkit for implementation of the European directive on prevention of sharps injuries.


(Council Directive 2010/32/EC) in member states. 2011. www.europeanbiosafetynetwork.eu/ EBN%20Toolkit%202011.pdf (accessed 14 March 2014).


19. Health and Safety Executive (HSE). Information Sheet MISC615 Safe handling of cytotoxic drugs. www.hse. gov.uk/pubns/misc615.pdf (accessed 14 March 2014).


20. Department of Health (DH). Immunisation Against Infectious Disease. 2006 The Stationery Office, London. www.wp.dh.gov.uk/immunisation/ files/2012/07/Green-Book-original-2006.pdf (accessed 14 March 2014).


21. Department of Health (DH). HIV Post-Exposure Prophylaxis: Guidance from the UK Chief Medical Officers’ Expert Advisory Group on AIDS. 2008. The Stationery Office, London. www.dh.gov.uk/prod_ consum_dh/groups/dh_digitalassets/@dh/@en/ documents/digitalasset/dh_089997.pdf (accessed 14 March 2014).


22. Mindmetre. Safer Sharps? A barometer of take-up in the UK, 2014. www.mindmetreresearch.com/ wp-content/uploads/2014/02/ Safer-sharps_A-barometer-of-take-up-in-the-UK_ report.pdf (accessed 14 March 2014).


23. Health and Safety Executive (HSE). HSE Improvement notices against the H & S (Sharp Instruments in Healthcare) Regulations 2013b. http://www.hse.gov. uk/notices/notices/notice_list.asp?ST=N&CO=&SN=P &SF=REG%2C+%7C&EO=%3D&SV=1116%2C+%7C&x =32&y=10 (accessed 14 March 2014).


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28